Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 142.55 USD -5.9% Market Closed
Updated: Jun 1, 2024

Moderna Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Moderna Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Moderna Inc
NASDAQ:MRNA
Accumulated Depreciation
-$465m
CAGR 3-Years
-51%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Moderna Inc's Accumulated Depreciation?
Accumulated Depreciation
-465m USD

Based on the financial report for Mar 31, 2024, Moderna Inc's Accumulated Depreciation amounts to -465m USD.

What is Moderna Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-45%

Over the last year, the Accumulated Depreciation growth was 37%. The average annual Accumulated Depreciation growth rates for Moderna Inc have been -51% over the past three years , -45% over the past five years .